These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2826829)

  • 1. Generic drugs: bioequivalence and bioavailability.
    Ansbacher R
    JAMA; 1988 Jan; 259(2):220. PubMed ID: 2826829
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic comparison between Conpremin (Premarin) and a generic preparation of conjugated estrogens.
    Arteaga E; Villaseca P
    Climacteric; 1998 Dec; 1(4):284-9. PubMed ID: 11907935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic conjugated estrogens.
    Arington ET
    Am Pharm; 1990 Oct; NS30(10):8. PubMed ID: 2173388
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioequivalence of conjugated estrogen products.
    Ansbacher R
    Clin Pharmacokinet; 1993 Apr; 24(4):271-4. PubMed ID: 8387902
    [No Abstract]   [Full Text] [Related]  

  • 5. Conjugated estrogens: do not substitute.
    Ansbacher R
    Am Pharm; 1990 Jul; NS30(7):27-8. PubMed ID: 2163583
    [No Abstract]   [Full Text] [Related]  

  • 6. Conjugated estrogens: FDA's position.
    Burlington DB
    Am Pharm; 1990 Jul; NS30(7):28-9. PubMed ID: 2163584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Generic drugs, bioavailability, and bioequivalence].
    Palma-Aguirre JA
    Gac Med Mex; 1998; 134(4):491-4. PubMed ID: 9789395
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on the note for guidance on bioavailability and bioequivalence in the European Union.
    Calvo G
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():11. PubMed ID: 9800721
    [No Abstract]   [Full Text] [Related]  

  • 9. Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model.
    Walker SE; Friesen MH
    J Pharm Pharm Sci; 1999; 2(1):15-22. PubMed ID: 10951658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are therapeutic drugs freely interchangeable? Studies of bioavailability and bioequivalence].
    Blume H
    Verh Dtsch Ges Inn Med; 1988; 94():411-9. PubMed ID: 3061214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bioequivalence of generic drugs: sense and nonsense].
    Brune K; Dietzel K
    Fortschr Med; 1988 Nov; 106(33):16-7. PubMed ID: 3209169
    [No Abstract]   [Full Text] [Related]  

  • 12. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types of bioequivalence and related statistical considerations.
    Hauck WW; Anderson S
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bioequivalence of generic drugs].
    Schwabe U
    Internist (Berl); 1988 Mar; 29(3):147-59. PubMed ID: 3288573
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the bioavailability and bioequivalence of generic medications.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H
    Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioequivalence studies of pharmaceutical preparations].
    Vetchý D; Frýbortová K; Rabisková M; Danecková H
    Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends.
    Srinivas NR
    Arzneimittelforschung; 2009; 59(4):155-65. PubMed ID: 19517891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and bioequivalence: average, population and/or individual.
    Colburn WA; Keefe DL
    J Clin Pharmacol; 2000 Jun; 40(6):559-60. PubMed ID: 10868304
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview on bioavailability and bioequivalence.
    Kaplan SA
    Psychopharmacol Bull; 1976 Oct; 12(4):50-1. PubMed ID: 972989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.